ADVFN Logo
Registration Strip Icon for alerts Register for real-time alerts, custom portfolio, and market movers

MRKR Marker Therapeutics Inc

4.29
-0.02 (-0.46%)
Last Updated: 14:11:52
Delayed by 15 minutes
Company Name Stock Ticker Symbol Market Type
Marker Therapeutics Inc MRKR NASDAQ Common Stock
  Price Change Change Percent Stock Price Last Traded
-0.02 -0.46% 4.29 14:11:52
Open Price Low Price High Price Close Price Prev Close
4.25 4.09 4.40 4.31
more quote information »

Recent News

Date Time Source Heading
4/08/202407:00GLOBEPrincipal Investigator from City of Hope National Medical..
3/25/202417:45GLOBEMarker Therapeutics Reports Year-End 2023 Corporate and..
3/22/202412:30GLOBEMarker Therapeutics to Present at the H.C. Wainwright 2nd..
3/01/202408:02EDGAR2Form 8-K - Current report
2/26/202407:58EDGAR2Form 8-K - Current report
1/22/202407:30GLOBEMarker Therapeutics Receives Approval from United States..
1/08/202408:30EDGAR2Form 8-K - Current report
1/08/202408:24GLOBEMarker Therapeutics Announces Clinical Program Updates and..
12/21/202311:00GLOBEMarker Therapeutics Announces Participation in Biotech..
12/11/202307:35EDGAR2Form 8-K - Current report
12/11/202307:00GLOBEMarker Therapeutics Announces Sustained Complete Response in..
11/20/202316:37EDGAR2Form 8-K - Current report
11/09/202317:03EDGAR2Form 8-K - Current report
11/09/202317:00GLOBEMarker Therapeutics Reports Third Quarter 2023 Financial..
11/09/202316:31EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
9/11/202307:10EDGAR2Form 8-K - Current report
9/11/202307:00GLOBEMarker Therapeutics Announces Complete Response in First..
8/30/202308:00GLOBEMarker Therapeutics to Present at the H.C. Wainwright 25th..
8/14/202316:37EDGAR2Form 8-K - Current report
8/14/202316:30GLOBEMarker Therapeutics Reports Second Quarter 2023 Financial..
8/14/202316:03EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
8/07/202307:22EDGAR2Form 8-K - Current report
8/07/202307:00GLOBEMarker Therapeutics Reports Non-Clinical Proof-of-Concept..
7/26/202307:00GLOBEMarker Therapeutics to Participate in Virtual Roundtable..
7/10/202307:09EDGAR2Form 8-K - Current report
7/10/202307:00GLOBEEuropean Medicines Agency Grants Orphan Drug Designation for..
7/05/202316:22EDGAR2Form 3 - Initial statement of beneficial ownership of..
7/03/202316:05EDGAR2Form 8-K - Current report
6/30/202316:05EDGAR2Form 8-K - Current report
6/26/202307:00GLOBEMarker Therapeutics Reports MT-401 Non-Clinical Data in AML..
6/12/202307:00GLOBEMarker Therapeutics Announces First Lymphoma Patient Treated..
5/31/202306:30GLOBEMarker Therapeutics Reports Pre-Clinical Data of its MT-601..
5/08/202307:30GLOBEMarker Therapeutics Appoints Monic Stuart, M.D., as Chief..
5/01/202307:30GLOBEMarker Therapeutics Announces Comprehensive Non-Dilutive..

Your Recent History

Delayed Upgrade Clock